Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

London afternoon: Shares aim higher

Fri, 28th Aug 2009 14:27

London's blue chips have added to gains in afternoon trading ahead of what is expected to be a rosy start on Wall Street.US stocks are seen posting good gains after Intel hiked its third-quarter revenue outlook just before the open.Kazakhmys, Xstrata, Rio Tinto, Antofagasta, Randgold Resources, Anglo American and Vedanta Resources are all amongst the major risers.Lloyds is amongst the risers on rumours that it is considering alternatives to the government's toxic asset protection scheme (APS), which could include the sale of Scottish Widows or even a rights issue. The part-nationalised lender may also sell Clerical Medical, a provider of investment products and pensions.National Express dropped after it rejected the improved 450p per share offer from a consortium led by its main shareholder, saying that it undervalued the group and its prospects.Bus and rail operator Stagecoach said conditions remain challenging as it reported a 4.4% rise in like-for-like UK bus revenues and a 0.9% rise in UK rail revenues in the 12 weeks to July 26. Online gaming giant PartyGaming saw pre-tax profits rise at the half year stage, but revenues fell by 21% predominantly due to the strength of the dollar against the euro and sterling. Cost control measures and a refusal to slash prices helped Restaurant Group, the company behind the Frankie & Bennie's and Chiquito chains, to post a rise in profits for the first half of the year despite falling sales at its restaurants.Oil explorer Dana Petroleum reported a sharp drop in first half profits in what it called a very difficult macro economic environment. Profit before tax for the period was £21.9m from £133.1m last time. JKX Oil meanwhile saw lower oil prices crimp profits for the half-year but said its second half performance is expected to be in line with expectations.Oil explorer Heritage Oil reduced half year losses and said growth prospects never looked better, while fellow oil and gas firm Melrose Resources upgraded its full year production guidance but saw half-year results also hit by lower commodity prices.Independent News and Media, the Irish publisher of the UK's Independent newspaper, swung to a first-half net loss and said it expects full-year profits to be at the low end of guidance.Edinburgh based publisher Johnston Press said half year pre-tax losses swelled to £94m as revenues fell 25%. The group, which produces the Yorkshire Post and The Scotsman, said pre-tax loss swelled to £94.2m in the 26 Weeks to 30 June 2009 from a loss of £53.7m the year before. Revenue fell to £218.6m.Advertising firm Aegis saw profits slide in the first half of the year after the downturn in the sector proved more difficult than expected. Pre-tax profits for the period totalled £6.6m compared with £47.4m for the first half of 2008. Revenue climbed to £636.7m from £607.6m due to positive currency effects.Laundry and workwear firm Davis Service Group posted a slight fall in pre-tax profits in the first half of the year as it continued to experience tough trading in its main markets.Upmarket cooker maker Aga moved into the red in the half year to 30 June and expects Autumn sales to match levels seen the same time last year.Investment bank Evolution saw adjusted operating profit jump 102% in the half year ended 30 June to £9.1m as Investment Banking income rose 93% to £33.9m, mainly from more sustainable secondary equities and fixed income commissions.FTSE 100 - RisersKazakhmys (KAZ) 997.50p +6.46%Lloyds Banking Group (LLOY) 110.74p +5.77%Xstrata (XTA) 834.00p +5.30%Eurasian Natural Resources (ENRC) 870.00p +4.82%Randgold Resources (RRS) 3,642.00p +4.66%Lonmin (LMI) 1,476.00p +4.38%Wolseley (WOS) 1,463.00p +4.13%Antofagasta (ANTO) 770.00p +3.98%FTSE 100 - FallersSerco Group (SRP) 470.00p -2.67%Pennon Group (PNN) 461.50p -1.33%BG Group (BG.) 1,032.00p -0.86%Schroders NV (SDRC) 911.00p -0.82%United Utilities Group (UU.) 462.20p -0.75%National Grid (NG.) 600.00p -0.66%Cobham (COB) 202.80p -0.64%Schroders (SDR) 1,080.00p -0.64%
More News
23 Nov 2020 17:37

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial

IN BRIEF: Evgen Pharma Doses First Patient In Lead Candidate Trial

Read more
23 Nov 2020 12:22

Evgen doses first patients in 'STAR' respiratory trial

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Monday that the first patient had now been enrolled and dosed in the 'STAR' trial of its 'SFX-01' treatment for acute respiratory infections.

Read more
11 Nov 2020 15:53

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment

IN BRIEF: Evgen Pharma About To Begin SFX-01 Trial Recruitment

Read more
23 Oct 2020 11:49

Evgen gets full approval for SFX-01 trial in Covid-19 patients

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced on Friday that all necessary regulatory approvals had now been received for the 'STAR' trial of SFX-01 treatment for Acute Respiratory Infections.

Read more
23 Oct 2020 11:31

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial

Shares In Evgen Pharma Rise On Approval For SFX-01 Trial

Read more
23 Oct 2020 10:46

UK WINNERS & LOSERS SUMMARY: Barclays Lifts FTSE's Lenders

UK WINNERS & LOSERS SUMMARY: Barclays Lifts FTSE's Lenders

Read more
24 Sep 2020 18:12

UK EXECUTIVE CHANGE SUMMARY: Carr's Names Pelham To Replace CEO Davies

UK EXECUTIVE CHANGE SUMMARY: Carr's Names Pelham To Replace CEO Davies

Read more
15 Sep 2020 22:08

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

UK TRADING UPDATE SUMMARY: Mortgage Advice Bureau Launches Later Life

Read more
15 Sep 2020 08:41

Evgen Pharma licences technology to Juvenescence

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced the licensing of its sulforaphane stabilisation technology in a number of non-pharmaceutical applications to Juvenescence on Tuesday.

Read more
9 Jul 2020 16:16

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

Read more
17 Jun 2020 12:01

Evgen's 'SFX-01' to be tested with Covid-19 patients

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced its participation in the recently-notified funding initiative for Covid-19 clinical trials by the medical research charity LifeArc on Wednesday.

Read more
17 Jun 2020 10:42

Evgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial

Evgen Pharma Says SFX-01 To Be Evaluated In Covid-19 Trial

Read more
15 Jun 2020 11:09

UK WINNERS & LOSERS SUMMARY: Bunzl Rises As It Sees Strong First Half

UK WINNERS & LOSERS SUMMARY: Bunzl Rises As It Sees Strong First Half

Read more
15 Jun 2020 10:24

Evgen Pharma Loss Slightly Wider On Expenses And Compensation

Evgen Pharma Loss Slightly Wider On Expenses And Compensation

Read more
15 Jun 2020 09:51

Losses widen as Evgen Pharma develops SFX-01

(Sharecast News) - Clinical-stage drug development company Evgen Pharma reported a slight widening of its post-tax loss in its final results on Monday, to £2.7m, from £2.6m in the prior year.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.